Digital Therapeutics Market: North America Accounted For The Largest Share

 Digital Therapeutics Industry Overview

The global digital therapeutics market size was valued at USD 4.20 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 26.1% from 2022 to 2030. Increasing smartphone penetration in developed & developing countries, the cost-effectiveness of digital health technology for providers & patients, and increasing demand for integrated healthcare systems & patient-centric care are expected to drive the market. According to Kepios, in April 2021, there were 4.27 billion internet users globally, which is over 60% of the global population. As this number increases, the awareness about smart health tracking is expected to improve. Furthermore, the COVID-19 pandemic, supportive regulatory initiatives & early signs of reimbursement, and increasing prevalence of chronic diseases are also anticipated to fuel the market growth.

The COVID-19 pandemic significantly impacted the market. A major COVID-related driver is a rise in demand for convenient and accessible digital health solutions. The April 2020 guidelines released by the FDA stated that for the duration of the pandemic, it will allow the distribution and use of digital health therapeutic devices for mental health disorders. Providers can, thus, commercialize their solutions without complying with usual regulatory requirements, provided the devices do not create any undue public health emergency. Growing regulatory initiatives are anticipated to propel the standardization and R&D in the market over the forecast period.

 

Gather more insights about the market drivers, restrains and growth of the Global Digital Therapeutics market

For instance, the Software Pre-Cert Pilot Program is part of the Digital Health Innovation Action Plan of the FDA, intended for a more efficient regulatory oversight of Software-based Medical Devices (SaMD) developed by manufacturers. The program is aimed at developing an efficient regulatory oversight for assessing organizations to establish trust that they can develop high-quality SaMD products. As per the CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have 2 or more chronic diseases. Cardiovascular diseases, cancer, diabetes, chronic kidney disease, chronic lung disease, and Alzheimer’s have been identified as the leading causes of death and disability in the country.

Poor nutrition, use of tobacco, alcoholism, and lack of physical exercise further increase the risk of developing a chronic disease. Healthcare costs are impacted exponentially as most chronic diseases do not exist in isolation and a patient often suffers from co-morbidities. Smartphone ownership is even becoming essential with improving global interconnectivity, economically and socially. Smartphone penetration is an important factor related to the growth of the market.


Browse through Grand View Research's Healthcare IT Industry Research Reports.

  • Electronic Data Capture Systems Market - The global electronic data capture systems market size was valued at USD 1.25 billion in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.6% from 2023 to 2030.

 

  • E-Prescribing Market - The global e-prescribing market size was estimated at USD 2.89 billion in 2022 and it is anticipated to witness a compound annual growth rate (CAGR) of 26.8% during the forecast period.

 

Digital Therapeutics Market Segmentation

Grand View Research has segmented the Digital therapeutics market on the basis of application, end user, and region:

Digital Therapeutics Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Diabetes
  • Obesity
  • CVD
  • Respiratory Diseases
  • Smoking Cessation
  • CNS Diseases
  • Others

Digital Therapeutics End-user Outlook (Revenue, USD Million, 2017 - 2030)

  • Patients
  • Providers
  • Payers
  • Employers
  • Others

Digital Therapeutics Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • December 2021: Teladoc expanded its partnership with the National Labor Alliance for offering its full suite of virtual care products and services. These products and services included specialty care, general medical, expert medical services, mental health, virtual primary care programs, and chronic condition management.


Key Companies profiled:

Some of the key players in the global digital therapeutics market include:

  • OMADA HEALTH, INC.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Teladoc Health, Inc.
  • Propeller Health (ResMed)
  • Fitbit LLC
  • CANARY HEALTH
  • Noom, Inc. 
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth Corp.
  • BigHealth 
  • GAIA AG
  • Limbix Health, Inc. 

 

Order a free sample PDF of the Digital Therapeutics Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more